ICPA ICPAMOX-CV 625

ICPA ICPAMOX-CV 62

Composition:

Amoxycillin 500mg + Clavulanic acid 125mg Tablet

Introduction:

ICPAMOX-CV 625 is an antibiotic agent with a broad-spectrum activity against the commonly occurring bacterial pathogens in the oral cavity and other parts of the body. The beta-lactamase inhibitory action of clavulanic acid extends the spectrum of amoxycillin to embrace a wider range of organisms, including many resistant to other beta-lactam antibiotics.

Indications:

ICPAMOX-CV improves treatment success rate in,

1. Acute periapical abscess; along with endo treatment

2. Before starting endo treatment; to reduce post-operative pain

3. Tooth extraction & other oral surgeries; to reduce post-operative infection and bacteremia

4. Before wisdom tooth surgeries; to prevent post-operative infection & dry socket

5. Pericoronitis & Peri-implantitis

6. Periodontitis (as an adjunct to scaling & root planing), periodontal surgeries, periodontal abscess.

7. Facial cellulitis